Pentetate Sodium Calcium Hydrate for Radiopharmaceutical Preparations
Pentetate Sodium Calcium Hydrate for Radiopharmaceutical Preparations Impurities & Reference Standards
Pentetate Sodium Calcium Hydrate for Radiopharmaceutical Preparations is recognized as an active pharmaceutical ingredient (API) that supports formulation development, process validation, and quality assurance in drug manufacturing. These Pentetate Sodium Calcium Hydrate for Radiopharmaceutical Preparations reference impurities are critical for pharmaceutical quality control, method validation, and regulatory filings aligned with ICH, USP, BP, and EP standards. We supply certified Pentetate Sodium Calcium Hydrate for Radiopharmaceutical Preparations reference standards and impurity markers with complete documentation, including a Certificate of Analysis (CoA), HPLC chromatograms, and spectroscopic data, for pharmaceutical research, manufacturing, and regulatory use.
Associated Impurities
Pentetate Sodium Calcium Hydrate for Radiopharmaceutical Preparations Impurity – A
- CAS No: 139-13-9
- Mol. F.: C6H9NO6
Pentetate Sodium Calcium Hydrate for Radiopharmaceutical Preparations Impurity – B
- CAS No: 67-43-6
- Mol. F.: C14H23N3O10